Novavax, Inc. (NVAX) was a big mover last session, as its shares rose a little over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $4.05 to $4.69 in the past one-month time frame.
In the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.
Novavax currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked biomedical stocks include Halozyme Therapeutics, Inc. (HALO), Merrimack Pharmaceuticals, Inc. (MACK) and Myriad Genetics Inc. (MYGN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment